View Item 

Show simple item record

ADENOSINE DEAMINASE AND IMMUNE FUNCTION
dc.contributor.authorVan Der Weyden, Martin B.en_US
dc.contributor.authorKelley, William N.en_US
dc.date.accessioned2010-06-01T20:59:24Z
dc.date.available2010-06-01T20:59:24Z
dc.date.issued1976-10en_US
dc.identifier.citationVAN DER Weyden, Martin B.; Kelley, William N. (1976). "ADENOSINE DEAMINASE AND IMMUNE FUNCTION." British Journal of Haematology 34(2): 159-165. <http://hdl.handle.net/2027.42/74083>en_US
dc.identifier.issn0007-1048en_US
dc.identifier.issn1365-2141en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74083
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=788771&dopt=citationen_US
dc.format.extent556798 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1976 Blackwell Science Ltden_US
dc.titleADENOSINE DEAMINASE AND IMMUNE FUNCTIONen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical School, University Hospital, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Medicine, Monash University Medical School, Alfred Hospital, Melbourne, Victoria, Australiaen_US
dc.identifier.pmid788771en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74083/1/j.1365-2141.1976.tb00187.x.pdf
dc.identifier.doi10.1111/j.1365-2141.1976.tb00187.xen_US
dc.identifier.sourceBritish Journal of Haematologyen_US
dc.identifier.citedreferenceALLISON, A.C., HOVI, T., WATTS, R.W. E. & WEBSTER, A.D.B. ( 1975 ) Immunological observations on patients with Lesch-Nyhan syndrome and on the role of de novo purine synthesis in lymphocyte transformation. Lancet, II, 1179.en_US
dc.identifier.citedreferenceBLUME, A.J. & FOSTER, C.J. ( 1975 ) Mouse neuroblastoma adenylate cyclase. Adenosine and adenosine analogues as potent effectors of adenylate cyclase activity. Journal of Biological Chemistry, 250, 5003.en_US
dc.identifier.citedreferenceBOURNE, H.R., LICHENSTEIN, L.M., MELMON, K.L., HENNEY, C.S. & WEINSTEIN, Y. ( 1974 ) Modulation of inflammation and immunity by cyclic AMP. Science, 184, 19.en_US
dc.identifier.citedreferenceCARSON, D.A. & SEEGMILLER, J.E. ( 1976 ) Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. Journal of Clinical Investigation, 57, 274.en_US
dc.identifier.citedreferenceCHAMBERS, D.A., MARTIN, D.W., JR & WEINSTEIN, Y. ( 1974 ) The effect of cyclic nucleotides on purine biosynthesis and the induction of PRPP synthetase during lymphocyte activation. Cell, 3, 375.en_US
dc.identifier.citedreferenceCHEN, S.-H., SCOTT, C.R. & GIBLETT, E.R. ( 1974 ) Adenosine deaminase: demonstration of a silent gene associated with combined immunodeficiency disease. American Journal of Human Genetics, 26, 103.en_US
dc.identifier.citedreferenceCHEN, S.-H., SCOTT, C.R. & SWEDBERG, K.R. ( 1975 ) Heterogeneity for adenosine deaminase deficiency: expression of the enzyme in cultured fibroblasts and amniotic fluid cells. American Journal of Human Genetics, 27, 46.en_US
dc.identifier.citedreferenceEDWARDS, J.H., ALLEN, F.H., GLENN, K.P., LAMM, L.U. & ROBSON, E.B. ( 1973 ) The linkage relationship of HL-A. Histocompatability Testing, 1972 ( Ed. by J. Dausset and J. Colombani ), p 745. Munskgaard, Copenhagen.en_US
dc.identifier.citedreferenceFISCHER, D., VAN DER WEYDEN, M.B., SNYDERMAN, R. & KELLEY, W.N. ( 1976 ) A role for adenosine deaminase in human monocyte maturation. Journal of Clinical Investigation, ( in press ).en_US
dc.identifier.citedreferenceFOX, I.H., KEYSTONE, E.C., GLADMAN, D.D., MOORE, M. & CANE, D. ( 1975 ) Inhibition of mitogen mediated lymphocyte blastogenesis by adenosine. Immunological Communications, 4, 419.en_US
dc.identifier.citedreferenceGIBLETT, E.R., ANDERSON, J.E., COHEN, F., POLLARA, B. & MEUWISSEN, H.J. ( 1972 ) Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet, II, 1067.en_US
dc.identifier.citedreferenceGIBLETT, E.R., AMMAN, A.J., WARA, D.W., SANDMAN, R. & DIAMOND, L.K. ( 1975 ) Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet, I, 1010.en_US
dc.identifier.citedreferenceGOLDBLUM, R.M., SCHMALSTIEG, F.C., NELSON, A., MONAHAN, T. & MILLS, G. ( 1976 ) Elevated levels of lymphocyte adenine nucleotides in adenosine deaminase deficiency. (Abstract). Clinical Research, 24, 68A.en_US
dc.identifier.citedreferenceGREEN, H. & CHAN, T.-S. ( 1973 ) Pyrimidine starvation induced by adenosine in fibroblasts and lymphoid cells: role of adenosine deaminase. Science, 182, 836.en_US
dc.identifier.citedreferenceHALL, J.G. ( 1963 ) Adenosine deaminase in lymphoid cells during antibody production. Australian Journal of Experimental Biology, 41, 93.en_US
dc.identifier.citedreferenceHIRSCHHORN, R., GROSSMAN, J. & WEISSMAN, G. ( 1970 ) Effect of cyclic 3', 5'-adenosine monophosphate and theophylline on lymphocyte transformation. Proceedings of the Society for Experimental Biology and Medicine, 133, 1361.en_US
dc.identifier.citedreferenceHIRSCHHORN, R., BERATIS, N., ROSEN, F.S., PARKMAN, R., STERN, R. & POLMAR, S. ( 1975 ) Adenosine deaminase deficiency in a child diagnosed prenatally. Lancet, I, 73.en_US
dc.identifier.citedreferenceHIRSCHHORN, R., BERATIS, N. & ROSEN, F.S. ( 1976 ) Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme. Proceedings of the National Academy of Sciences of the United States of America, 73, 104.en_US
dc.identifier.citedreferenceHOLMES, E.W., WYNGAARDEN, J.B. & KELLEY, W.N. ( 1973 ) Human glutamine phosphoribosylpyro-phosphate amidotransferase. Two molecular forms interconvertable by purine ribonucleotides and phosphoribosylpyrophosphate. Journal of Biological Chemistry, 248, 6035.en_US
dc.identifier.citedreferenceHOVI, T., SMYTH, J.F., ALLISON, A.C. & WILLIAMS, S.C. ( 1976 ) Role of adenosine deaminase in lymphocyte proliferation. Clinical and Experimental Immunology, 23, 395.en_US
dc.identifier.citedreferenceHUANG, M. & DALY, J.W. ( 1974 ) Adenosine-elicited accumulation of cyclic adenosine monophosphate in brain slices: potentiation of agents which inhibit the uptake of adenosine. Life Sciences, 14, 489.en_US
dc.identifier.citedreferenceHUANG, A.T., ENGELBRECHT, H.L., LOGUE, G.L. & SANAL, O. ( 1975 ) A biochemical difference in human lymphocyte subpopulations separated by complement-mediated rosette method. (Abstract). Blood, 46, 1035.en_US
dc.identifier.citedreferenceHUTTON, J.J. & COLEMAN, M.S. ( 1975 ) Activity of adenosine deaminase in lymphoproliferative diseases. (Abstract). Clinical Research, 23, 425A.en_US
dc.identifier.citedreferenceISHII, K. & GREEN, H. ( 1973 ) Lethality of adenosine for cultured mammalian cells by interference with pyrimidine biosynthesis. Journal of Cell Science, 13, 429.en_US
dc.identifier.citedreferenceKIM, B.K., CHA, S. & PARKS, R.E., JR ( 1968 ) Purine nucleoside phosphorylase from human erythrocytes. 1. Purification and properties. Journal of Biological Chemistry, 243, 1763.en_US
dc.identifier.citedreferenceKNUDSEN, B.B. & DISSING, J. ( 1973 ) Adenosine deaminase deficiency in a child with severe combined immunodeficiency. Clinical Genetics, 4, 344.en_US
dc.identifier.citedreferenceKOEHLER, L.M. & BENZ, E.J. ( 1962 ) Serum adenosine deaminase: methodology and clinical applications. Clinical Chemistry, 8, 133.en_US
dc.identifier.citedreferenceLI, C.-C. & HOCHSTADT, J. ( 1976 ) Transport mechanisms in isolated plasma membranes. Journal of Biological Chemistry, 251, 1175.en_US
dc.identifier.citedreferenceLOMAX, C.A. & HENDERSON, J.F. ( 1973 ) Adenosine formation and metabolism during adenosine triphosphate catabolism in Ehrlich ascites tumor cells. Cancer Research, 33, 2825.en_US
dc.identifier.citedreferenceMCCAFFREY, R., GREAVES, M., HARRISON, T.A., REVERZS, T., BEARD, M. & BALTIMORE, D. ( 1975 ) Biochemical and immunological evidence for lymphoblastic conversion in chronic myelogenous leukemia. (Abstract). Blood, 46, 1043.en_US
dc.identifier.citedreferenceMENDELSOHN, J., PARMER, R.J. & MULTER, M.M. ( 1975 ) Altered cyclic AMP metabolism in chronic lymphocytic leukemia lymphocytes. (Abstract). Blood, 46, 1044.en_US
dc.identifier.citedreferenceMILLIS, A.J.T., FORREST, G.A. & PIOUS, D.A. ( 1974 ) Cyclic AMP dependent regulation of mitosis in human lymphoid cells. Experimental Cell Research, 83, 335.en_US
dc.identifier.citedreferenceMILLS, D.C.B. & SMITH, J.B. ( 1971 ) The influence of platelet aggregation of drugs that affect the accumulation of adenosine 3', 5' cyclic monophosphate in platelets. Biochemical Journal, 121, 185.en_US
dc.identifier.citedreferencePARKMAN, R., GELFAND, E.W., ROSEN, F.W., SANDERSON, A. & HIRSCHHORN, R. ( 1975 ) Severe combined immunodeficiency and adenosine deaminase deficiency. New England Journal of Medicine, 292, 975.en_US
dc.identifier.citedreferencePARKS, R.E., JR & BROWN, P.R. ( 1973 ) Incorporation of nucleosides into the nucleotide pools of human erythrocytes. Adenosine and its analogs. Biochemistry, 12, 3294.en_US
dc.identifier.citedreferencePATERSON, A.R.P. ( 1965 ) The biosynthesis of extracellular ribonucleosides by ascites tumor cells in vitro. Canadian Journal of Biochemistry, 43, 257.en_US
dc.identifier.citedreferencePOLMAR, S.H., WETZLER, E.M., STERN, R.C. & HIRSCHHORN, R. ( 1975 ) Restoration of in vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency. Lancet, II, 743.en_US
dc.identifier.citedreferenceSATTIN, A. & RALL, T.W. ( 1970 ) The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5' phosphate content of guinea pig cerebral cortex slices. Molecular Pharmacology, 6, 13.en_US
dc.identifier.citedreferenceSCHMALSTEIG, F.C., MILLS, G. & GOLDBLUM, R.M. ( 1976 ) Purine and pyrimidine metabolism in adenosine deaminase deficiency. (Abstract). Clinical Research, 24, 69A.en_US
dc.identifier.citedreferenceSCHRADER, J., BERNE, R.M. & RUBIO, R. ( 1972 ) Uptake and metabolism of adenosine by human erythrocyte ghosts. American Journal of Physiology, 223, 159.en_US
dc.identifier.citedreferenceSCOTT, C.R., CHEN, S.-H. & GIBLETT, E.R. ( 1974 ) Detection of the carrier state in combined immunodeficiency associated with adenosine deaminase deficiency. Journal of Clinical Investigation, 53, 1194.en_US
dc.identifier.citedreferenceSHIMIZU, H. & DALY, J. ( 1970 ) Formation of cyclic adenosine 3',5' monophosphate from adenosine in brain slices. Biochitnica et Biophysica Acta, 222, 465.en_US
dc.identifier.citedreferenceSMITH, L.H., JR, HUGULEY, C.M., JR & BAIN, J.A. ( 1972 ) Hereditary orotic aciduria. Metabolic Basis of Inherited Diseases ( Ed. by J. B. Stanbury, J. B. Wyngaarden and D. S. Fredrickson ), p 1003. McGraw-Hill, New York.en_US
dc.identifier.citedreferenceSMYTH, J.F. & HARRAP, K.R. ( 1975 ) Adenosine deaminase activity in leukaemia. British Journal of Cancer, 31, 544.en_US
dc.identifier.citedreferenceTISCHFIELD, J.A., CREAGAN, R.P., NICHOLS, E.A. & RUDDLE, F.H. ( 1974 ) Assignment of a gene for adenosine deaminase to human chromosome 20. Human Heredity, 24, 1.en_US
dc.identifier.citedreferenceTRAMS, E.G. & LAUTER, C.J. ( 1975 ) Adenosine deaminase in cultured brain cells. Biochemical Journal, 152, 681.en_US
dc.identifier.citedreferenceTROTTA, P.P., SMITHWICK, E.M. & BALIS, M.E. ( 1976 ) A normal level of adenosine deaminase activity in red cell lysates of carriers and patients with severe combined immunodeficiency. Proceedings of the National Academy of Sciences of the United States of America, 73, 104.en_US
dc.identifier.citedreferenceTUNG, R., SILBER, R., QUAGLIATA, F., CONKLYN, M., GOTTESMAN, J. & HIRSCHHORN, R. ( 1976 ) Adenosine deaminase activity in chronic lymphocytic leukemia. Journal of Clinical Investigation, 57, 756.en_US
dc.identifier.citedreferenceVAN DER WEYDEN, M.B. ( 1976 ) Unpublished observations.en_US
dc.identifier.citedreferenceVAN DER WEYDEN, M.B., BUCKLEY, R.H. & KELLEY, W.N. ( 1974 ) Molecular form of adenosine deaminase in severe combined immunodeficiency. Biochemical and Biophysical Research Communications, 57, 590.en_US
dc.identifier.citedreferenceVAN DER WEYDEN, M.B. & KELLEY, W.N. ( 1976a ) Catalytic and physical characteristics of residual adenosine deaminase activity in severe combined immunodeficiency. ( In preparation ).en_US
dc.identifier.citedreferenceVAN DER WEYDEN, M.B. & KELLEY, W.N. ( 1976b ) Human adenosine deaminase: distribution and properties. Journal of Biological Chemistry ( in press ).en_US
dc.identifier.citedreferenceVAN DER WEYDEN, M.B. & KELLEY, W.N. ( 1976c ) Unpublished observations.en_US
dc.identifier.citedreferenceWADA, Y., NISHIMURA, Y., TANABU, M., YOSHIMURA, Y., IINUMA, K., YOSHIDA, T. & ARAKAWA, T. ( 1974 ) Hypouricemic, mentally retarded infant with a defect of 5-phosphoribosyl-1-pyrophosphate synthetase of erythrocytes. Tohoku Journal of Experimental Medicine, 113, 149.en_US
dc.identifier.citedreferenceWOLBERG, G., ZIMMERMAN, T.P., HIEMSTRA, K., WINSTON, M. & CHU, L.-C. ( 1975 ) Adenosine inhibition of lymphocyte-mediated cytolysis: a possible role for cyclic adenosine monophosphate. Science, 187, 957.en_US
dc.identifier.citedreferenceZIMMER, J., KHALIFA, A.S. & LIGHTBODY, J.J. ( 1975 ) Decreased lymphocyte adenosine deaminase activity in acute lymphocytic leukemic children and their parents. Cancer Research, 35, 68.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2141.1976.tb00187.x.pdf
Size:
543.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.